Search

everythinglearnresearchcommunity

for

Search:↓

Cannabidiol shows promise as an effective treatment for acne.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Ozone therapy might improve cancer treatment and reduce its side effects.

Nanotechnology improves minoxidil treatment for hair loss.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.